Zobrazeno 1 - 10
of 37
pro vyhledávání: '"H. H., Vora"'
Publikováno v:
The International Journal of Biological Markers. 21:74-80
There is growing interest in assessing multistep carcinogenesis and predicting its course using different molecular markers. TP53 is a tumor suppressor gene and appears to be one of the molecular targets of tobacco-related carcinogens in oral cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa6cae0e36952ff8f617f92d132c61e7
https://doi.org/10.1177/172460080602100202
https://doi.org/10.1177/172460080602100202
Publikováno v:
Headneck. 22(3)
The purpose of this study was to assess the role of prolactin (PRL) in men with locally advanced tongue cancer.Circulating PRL was assayed immunoradiometrically in pretherapeutic and sequential blood samples of 99 patients with locally advanced tongu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9c04e04ea13cf6931fed413305424311
https://pubmed.ncbi.nlm.nih.gov/10748449
https://pubmed.ncbi.nlm.nih.gov/10748449
Autor:
B. P., Parikh, S. P., Patel, B. N., Raiya, H. H., Vora, D. H., Jetly, Parikh, B P, Patel, S P, Raiya, B N, Vora, H H, Jetly, D H
Publikováno v:
Indian Journal of Cancer; Jul-Sep2016, Vol. 53 Issue 3, p349-352, 4p
Autor:
J M, Bhatavdekar, D D, Patel, N H, Karelia, N G, Shah, N, Ghosh, H H, Vora, T P, Suthar, D B, Balar, S S, Doctor
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 20(2)
The antiestrogen tamoxifen (TAM) is an effective therapy for advanced breast cancer. However, its use is limited by the eventual development of acquired TAM resistance in many patients. There is now strong evidence to suggest that prolactin plays an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5b05d496aa4997cd4d84114071061b7b
https://pubmed.ncbi.nlm.nih.gov/8181575
https://pubmed.ncbi.nlm.nih.gov/8181575
Circulating prolactin and tumoral prolactin receptors in men with tongue cancer: a preliminary study
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 20(2)
Pre-therapeutic circulating prolactin levels and tumoral prolactin receptors (PRLR) were determined in 25 male patients with tongue cancer. The patients were divided into PRLR positive (PRLR+) and PRLR negative (PRLR-) groups. The overall survival wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4673e23e3cc1cad172189593385572ef
https://pubmed.ncbi.nlm.nih.gov/8181582
https://pubmed.ncbi.nlm.nih.gov/8181582
Autor:
D D, Patel, J M, Bhatavdekar, N, Ghosh, H H, Vora, N H, Karelia, N G, Shah, T P, Suthar, D B, Balar, C R, Trivedi
Publikováno v:
Cancer. 73(3)
Preoperative plasma prolactin and carcinoembryonic antigen (CEA) levels were assessed to monitor disease recurrence and to identify low-risk and high-risk patients with Dukes B or C colorectal cancer.Prolactin and CEA were estimated by radioimmunoass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6860c44be40aba46c16a0dfdbfa5a47a
https://pubmed.ncbi.nlm.nih.gov/8299078
https://pubmed.ncbi.nlm.nih.gov/8299078
Autor:
J M, Bhatavdekar, D D, Patel, P R, Chikhlikar, R H, Mehta, H H, Vora, N H, Karelia, N, Ghosh, N G, Shah, T P, Suthar, J P, Neema
Publikováno v:
Neoplasma. 41(2)
Levels of circulating peptide (FSH, LH, prolactin, ACTH, calcitonin, gastrin and insulin-like growth factor-1 [IGF-1]) and steroid (estradiol, progesterone, DHEA-S and testosterone) hormones were estimated by radioimmunoassay (RIA) and immunoradiomet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::62e026415456b0339db6d3912577a9fa
https://pubmed.ncbi.nlm.nih.gov/8208311
https://pubmed.ncbi.nlm.nih.gov/8208311
Autor:
J M, Bhatavdekar, D D, Patel, G V, Sherbet, D D, Giri, N H, Karelia, H H, Vora, N G, Shah, T P, Suthar, S P, Nadkarni, D B, Balar
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 19(5)
Having established prolactin to be an indicator of disease progression and hyperprolactinemia as an independent predictor of short term prognostication, we have in this report compared plasma prolactin with the expression of c erb B-2 oncoprotein, ER
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f56e5d47a4b791c73c8e719bbe83cff6
https://pubmed.ncbi.nlm.nih.gov/8104829
https://pubmed.ncbi.nlm.nih.gov/8104829
Autor:
J M, Bhatavdekar, D D, Patel, N H, Karelia, T P, Suthar, N G, Shah, H H, Vora, N, Ghosh, S P, Nadkarni, D B, Balar
Publikováno v:
Neoplasma. 40(3)
Estrogen and progesterone receptors (ER and PR) were estimated in 129 synchronous (primary and metastatic lymph node) breast cancer tissues, of which 40% were premenopausal and 60% were postmenopausal. ER and PR accordance was seen in 68% and 70% pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::970e4f116e56b7e7ee420755fad53294
https://pubmed.ncbi.nlm.nih.gov/8350965
https://pubmed.ncbi.nlm.nih.gov/8350965
Publikováno v:
Anticancer research. 13(1)
Serum prolactin and tissue polypeptide specific antigen (TPS) were assayed pretherapeutically and sequentially thereafter in 20 male patients with advanced (stages III and IV) tongue cancer. The markers were correlated with disease stage, histologic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d22bf32a1c7a09342d55e883e70d7317
https://pubmed.ncbi.nlm.nih.gov/7682801
https://pubmed.ncbi.nlm.nih.gov/7682801